(Q40539646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Ching-Chuan Kuo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Wen-Yu Pan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ching-Ping Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jing-Ping Liou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Shiow-Ju Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Yi-Ling Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Li-Tzong Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Chiung-Tong Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jang-Yang Chang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

4621-4628

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

30 December 2019

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1128/MCB.19.12.8469

Identifiers

DOI

10.1158/0008-5472.CAN-03-3474

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231674%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference